However, when the HspBP1-overexpressing version of each cell line was injected into mice, both BRCA1-proficient cell lines led to markedly lower tumor outgrowth and size than the control, whereas the BRCA1-deficient cells did not (Fig. 1E, F). This evidence concerns the gene BRCA1 and neoplasm.